Jacob Johnson
Stock Analyst at Stephens & Co.
(3.30)
# 913
Out of 4,610 analysts
81
Total ratings
45.61%
Success rate
3.62%
Average return
Main Sectors:
Stocks Rated by Jacob Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher | Initiates: Overweight | $680 | $598.61 | +13.60% | 1 | Oct 1, 2024 | |
| DHR Danaher | Initiates: Overweight | $315 | $270.03 | +16.65% | 1 | Oct 1, 2024 | |
| CDMO Avid Bioservices | Reiterates: Overweight | $12 | $10.63 | +12.89% | 7 | Sep 10, 2024 | |
| STE STERIS | Reiterates: Overweight | $260 | $231.02 | +12.54% | 5 | Aug 7, 2024 | |
| RGEN Repligen | Reiterates: Overweight | $170 | $136.71 | +24.35% | 4 | Jul 30, 2024 | |
| TKNO Alpha Teknova | Reiterates: Overweight | $5 | $4.92 | +1.63% | 5 | Jul 10, 2024 | |
| MASS 908 Devices | Reiterates: Overweight | $14 | $3.50 | +300.00% | 3 | May 13, 2024 | |
| MXCT MaxCyte | Reiterates: Overweight | $11 | $3.67 | +199.73% | 5 | Apr 23, 2024 | |
| CTLT Catalent | Reiterates: Equal-Weight | $64 | $60.59 | +4.80% | 4 | Apr 4, 2024 | |
| STVN Stevanato Group | Reiterates: Overweight | $38 | $18.97 | +100.32% | 2 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $17 | $7.89 | +115.46% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $2.5 | $1.70 | +47.06% | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $70 | $48.27 | +45.02% | 4 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $87 | $74.78 | +16.34% | 10 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $296.50 | +31.53% | 8 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $9 | $5.38 | +67.29% | 3 | Sep 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $16 → $18 | $13.94 | +29.12% | 5 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $6 | $3.16 | +89.87% | 2 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $29 | $24.54 | +18.17% | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $153 → $130 | $104.78 | +24.07% | 2 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $377 | $190.74 | +97.65% | 1 | Apr 7, 2022 |
Thermo Fisher
Oct 1, 2024
Initiates: Overweight
Price Target: $680
Current: $598.61
Upside: +13.60%
Danaher
Oct 1, 2024
Initiates: Overweight
Price Target: $315
Current: $270.03
Upside: +16.65%
Avid Bioservices
Sep 10, 2024
Reiterates: Overweight
Price Target: $12
Current: $10.63
Upside: +12.89%
STERIS
Aug 7, 2024
Reiterates: Overweight
Price Target: $260
Current: $231.02
Upside: +12.54%
Repligen
Jul 30, 2024
Reiterates: Overweight
Price Target: $170
Current: $136.71
Upside: +24.35%
Alpha Teknova
Jul 10, 2024
Reiterates: Overweight
Price Target: $5
Current: $4.92
Upside: +1.63%
908 Devices
May 13, 2024
Reiterates: Overweight
Price Target: $14
Current: $3.50
Upside: +300.00%
MaxCyte
Apr 23, 2024
Reiterates: Overweight
Price Target: $11
Current: $3.67
Upside: +199.73%
Catalent
Apr 4, 2024
Reiterates: Equal-Weight
Price Target: $64
Current: $60.59
Upside: +4.80%
Stevanato Group
Mar 25, 2024
Reiterates: Overweight
Price Target: $38
Current: $18.97
Upside: +100.32%
Mar 13, 2024
Reiterates: Equal-Weight
Price Target: $17
Current: $7.89
Upside: +115.46%
Mar 7, 2024
Reiterates: Equal-Weight
Price Target: $2.5
Current: $1.70
Upside: +47.06%
Feb 8, 2024
Reiterates: Equal-Weight
Price Target: $70
Current: $48.27
Upside: +45.02%
Feb 2, 2024
Maintains: Overweight
Price Target: $92 → $87
Current: $74.78
Upside: +16.34%
Oct 27, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $296.50
Upside: +31.53%
Sep 1, 2023
Maintains: Equal-Weight
Price Target: $8 → $9
Current: $5.38
Upside: +67.29%
Aug 21, 2023
Upgrades: Overweight
Price Target: $16 → $18
Current: $13.94
Upside: +29.12%
Jul 21, 2023
Reiterates: Overweight
Price Target: $6
Current: $3.16
Upside: +89.87%
Jul 17, 2023
Maintains: Overweight
Price Target: $27 → $29
Current: $24.54
Upside: +18.17%
May 16, 2022
Maintains: Overweight
Price Target: $153 → $130
Current: $104.78
Upside: +24.07%
Apr 7, 2022
Initiates: Overweight
Price Target: $377
Current: $190.74
Upside: +97.65%